Skip to main navigation Skip to search Skip to main content

HBsAg autologous red cell agglutination assay

  • H. Gong
  • , A. Wang
  • , Q. Zheng
  • , L. Xu
  • , Y. Guo
  • , Y. Wang
  • , M. Yang

Research output: Journal Publications and ReviewsRGC 22 - Publication in policy or professional journal

Abstract

Three lot of HBsAg autologous red cell agglutination kits (ARCA kit) have been qualified in lab, clinical trial and the stability confirmation have been performed. The sensitivity of the kits is 1ng/ml HBsAg. A, B, O, AB type of peripheral blood or antiagglutinated specimens can be used for assay. No Holk effect has been found. The repeated rate of 10 samples assayed for five times reached 100%. The specimens collected from HAV, HCV, Schistosoma Japonicum infected patients or RF positive patients do not interfere the test. The specificity of the kits is very high. 1712 clinical specimens were inspected comparing with the EIA kits in market. The relativity between the two methods is 0.985. 18 of the 26 specimens which two methods did not accord with each other have been confirmed. The false positive and missing detected for ARCA kits is 1, 3 and for EIA kits are 6, 8 respectively. ARCA kits are stable in 4 degrees C and 22 degrees C for more than one year. The kits can stand in 35 degrees C, 45 degrees C for 45 and 10 days without losing activity respectively.
Original languageEnglish
Pages (from-to)78-80
JournalZhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology
Volume11
Issue number1
Publication statusPublished - Mar 1997
Externally publishedYes

Fingerprint

Dive into the research topics of 'HBsAg autologous red cell agglutination assay'. Together they form a unique fingerprint.

Cite this